Allogeneic NK cells therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic NK cells therapy, covering 2019-11-14 to 2019-11-14. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Allogeneic NK Cells Therapy in Patients With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]